COCP
CocrystalANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-earnings company update on May 15, 2026 was operationally constructive: CDI-988 advanced through the first cohort, prevention and treatment cohorts started enrolling, and the company booked initial non-dilutive SBIR grant revenue. For a company of this size, continued execution on the lead norovirus asset matters more than near-term P&L noise.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Clinical execution depends on CRO enrollment, trial conduct, and supply-chain/vendor reliability, all of which management continues to flag as risks.
Momentum
83
Value
41
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.10 · Bull $2.20 · Bear $0.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $7.00
Why
Momentum83 · Δ7d -
Value41 · Δ7d +0.1
Sentiment63 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
83
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
63
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 83.2 / Value 41.1 / Sentiment 62.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$15.3M
Beta
1.19
Shares Out
13.78M
P/E (TTM) · Derived
-0.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.20
Rev YoY
-
EPS YoY
+61.6%
Gross Margin
-
Op Margin
-
Net Debt
-$9.86M
Current Ratio
5.78
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology